Physician profile
Akshay Kumar
NPI 1184025223
$5,503.43
in general payments reported to CMS, 2019-2025
7 companies · $2,159 in 2025
The $2,159 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,378 · 2023: $125 · 2024: $1,841 · 2025: $2,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,736 · Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,736.10 |
| Food and Beverage | $1,389.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,212.85 | 2022-2025 | Synergy Ablation System |
| Abbott Laboratories | $1,181.17 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Bolton Medical INC | $1,037.79 | 2022 | |
| W. L. Gore & Associates, INC. | $996.38 | 2024 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Abiomed | $893.21 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $169.22 | 2023-2025 | Farxiga, Wainua |
| Medical Device Business Services, INC. | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshay Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.